Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses
Regencell Bioscience shares jumped 8.5% to $44.96 in midday Friday trading, rebounding from Thursday’s 21.7% drop. The stock has seen heavy swings and trading halts, with no recent company updates. Bragar Eagel & Squire is investigating Regencell on behalf of shareholders. CEO Yat-Gai Au controls about 88.6% of shares, according to SEC filings.